First live birth after uterine transposition

Objective: To our knowledge, to report the first case of live birth of a child after uterine transposition (UT), pelvic radiotherapy, and subsequent uterine repositioning.Design: Case report. Setting: Tertiary referral cancer hospital. Patient(s): A 28-year-old nulligravid woman with left iliac and thoracic synchronous myxoid low-grade liposarcoma, which was resected with close margins.Intervention(s): The patient underwent UT before undergoing pelvic (60 Gy) and thoracic (60 Gy) radiation on October 25, 2018. After radiotherapy, her uterus was reimplanted in the pelvis on February 20, 2019.Main Outcome Measure(s): The patient became pregnant in June 2021 and experienced an uneventful pregnancy until 36 weeks, when the patient started preterm labor and had a cesarean section delivery on January 26, 2022.Result(s): A boy was delivered after a gestation period of 36 weeks and 2 days (2686 g and 46.5 cm), with Apgar scores of 5 and 9, respectively; both mother and child were discharged the following day. After 1 year of follow-ups, the infant maintained normal development and the patient showed no signs of recurrence. Conclusion(s): To our knowledge, this case of the first live birth after UT is a proof-of-concept for the viability of UT as a procedure to prevent infertility in patients requiring pelvic radiotherapy. (Fertil Steril & REG; 2023;120:188-93.& COPY;2023 by American Society for Reproductive Medicine.)

Automated summary

This is the first reported case of a live birth after uterine transposition, pelvic radiotherapy, and subsequent uterine repositioning. A 28-year-old nulligravid woman underwent uterine transposition before receiving pelvic and thoracic radiation therapy. After successful radiation treatment, her uterus was reimplanted in the pelvis. The patient became pregnant and delivered a healthy baby after 36 weeks of gestation.